ALP/Carbonic anhydrase-IN-1 is a dual inhibitor of carbonic anhydrase (CA) and alkaline phosphatase (ALP), with potential applications in the treatment of diseases involving dysregulated CA and ALP activity, such as cancer, glaucoma, and bone disorders.